S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.17%) $0.928
USD/NOK
(0.32%) $10.88
USD/GBP
(0.00%) $0.792
USD/RUB
(-0.18%) $92.41

Realtime updates for Biosergen AB [BIOSGN.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 06:44

-3.49% SEK 0.442

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 06:44):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases...

Stats
Today's Volume 6 793.00
Average Volume 105 035
Market Cap 84.96M
EPS SEK-0.150 ( 2023-11-30 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -1.260
ATR14 SEK0 (0.00%)

Biosergen AB Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biosergen AB Financials

Annual 2023
Revenue: SEK0
Gross Profit: SEK0 (0.00 %)
EPS: SEK-0.310
Q4 2023
Revenue: SEK0
Gross Profit: SEK0 (0.00 %)
EPS: SEK-0.0755
Q3 2023
Revenue: SEK0
Gross Profit: SEK-2 000.00 (0.00 %)
EPS: SEK-0.150
Q2 2023
Revenue: SEK0
Gross Profit: SEK-10 000.00 (0.00 %)
EPS: SEK-0.190

Financial Reports:

No articles found.

Biosergen AB

Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases. The company was founded in 2004 and is headquartered in Solna, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators